vs
Side-by-side financial comparison of Arteris, Inc. (AIP) and SBC Medical Group Holdings Inc (SBC). Click either name above to swap in a different company.
SBC Medical Group Holdings Inc is the larger business by last-quarter revenue ($39.6M vs $20.1M, roughly 2.0× Arteris, Inc.). SBC Medical Group Holdings Inc runs the higher net margin — 35.9% vs -42.2%, a 78.1% gap on every dollar of revenue. On growth, Arteris, Inc. posted the faster year-over-year revenue change (30.0% vs -10.9%). SBC Medical Group Holdings Inc produced more free cash flow last quarter ($51.2M vs $3.0M). Over the past eight quarters, Arteris, Inc.'s revenue compounded faster (24.7% CAGR vs -15.0%).
Arteris, Inc. is a multinational technology company headquartered in Campbell, California. It develops the network-on-chip (NoC) IP and system-on-chip (SoC) integration automation software that is used to create semiconductor chip and chiplet designs for a variety of devices, particularly in automotive electronics, artificial intelligence, machine learning, enterprise computing, communications, consumer, industrial, and aerospace & defense markets. The company specializes in the development a...
SBC Medical Group Holdings Inc. is a leading Japan-headquartered healthcare provider primarily focused on aesthetic medicine, dermatology, and anti-aging wellness services. It operates an extensive network of clinics across Japan, catering to both domestic patients and international medical tourists, with core offerings including cosmetic surgery and non-invasive skincare treatments.
AIP vs SBC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $20.1M | $39.6M |
| Net Profit | $-8.5M | $14.2M |
| Gross Margin | 90.8% | 73.1% |
| Operating Margin | -42.0% | 32.5% |
| Net Margin | -42.2% | 35.9% |
| Revenue YoY | 30.0% | -10.9% |
| Net Profit YoY | -3.7% | 117.2% |
| EPS (diluted) | $-0.19 | $0.15 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $20.1M | $39.6M | ||
| Q3 25 | $17.4M | $43.4M | ||
| Q2 25 | $16.5M | $43.4M | ||
| Q1 25 | $16.5M | $47.3M | ||
| Q4 24 | $15.5M | $44.4M | ||
| Q3 24 | $14.7M | $53.1M | ||
| Q2 24 | $14.6M | $53.1M | ||
| Q1 24 | $12.9M | $54.8M |
| Q4 25 | $-8.5M | $14.2M | ||
| Q3 25 | $-9.0M | $12.8M | ||
| Q2 25 | $-9.1M | $2.5M | ||
| Q1 25 | $-8.1M | $21.5M | ||
| Q4 24 | $-8.2M | $6.5M | ||
| Q3 24 | $-7.7M | $2.8M | ||
| Q2 24 | $-8.3M | $18.5M | ||
| Q1 24 | $-9.4M | $18.8M |
| Q4 25 | 90.8% | 73.1% | ||
| Q3 25 | 89.9% | 70.6% | ||
| Q2 25 | 89.4% | 69.2% | ||
| Q1 25 | 90.8% | 79.7% | ||
| Q4 24 | 89.8% | 76.3% | ||
| Q3 24 | 90.1% | 81.5% | ||
| Q2 24 | 90.0% | 74.2% | ||
| Q1 24 | 88.7% | 72.1% |
| Q4 25 | -42.0% | 32.5% | ||
| Q3 25 | -50.1% | 36.6% | ||
| Q2 25 | -50.0% | 33.6% | ||
| Q1 25 | -46.6% | 51.1% | ||
| Q4 24 | -45.9% | 10.6% | ||
| Q3 24 | -53.8% | 26.1% | ||
| Q2 24 | -51.1% | 51.4% | ||
| Q1 24 | -70.5% | 44.6% |
| Q4 25 | -42.2% | 35.9% | ||
| Q3 25 | -51.6% | 29.6% | ||
| Q2 25 | -55.3% | 5.7% | ||
| Q1 25 | -49.1% | 45.4% | ||
| Q4 24 | -53.0% | 14.7% | ||
| Q3 24 | -52.2% | 5.3% | ||
| Q2 24 | -57.2% | 34.8% | ||
| Q1 24 | -72.6% | 34.2% |
| Q4 25 | $-0.19 | $0.15 | ||
| Q3 25 | $-0.21 | $0.12 | ||
| Q2 25 | $-0.22 | $0.02 | ||
| Q1 25 | $-0.20 | $0.21 | ||
| Q4 24 | $-0.19 | $0.05 | ||
| Q3 24 | $-0.20 | $0.03 | ||
| Q2 24 | $-0.22 | $0.20 | ||
| Q1 24 | $-0.25 | $0.20 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $33.9M | $164.1M |
| Total DebtLower is stronger | — | $42.8M |
| Stockholders' EquityBook value | $-14.6M | $248.3M |
| Total Assets | $115.0M | $380.4M |
| Debt / EquityLower = less leverage | — | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $33.9M | $164.1M | ||
| Q3 25 | $39.0M | $127.4M | ||
| Q2 25 | $38.0M | $152.7M | ||
| Q1 25 | $42.3M | $132.1M | ||
| Q4 24 | $43.8M | $125.0M | ||
| Q3 24 | $48.7M | $137.4M | ||
| Q2 24 | $45.8M | — | ||
| Q1 24 | $44.8M | — |
| Q4 25 | — | $42.8M | ||
| Q3 25 | — | $21.1M | ||
| Q2 25 | — | $7.1M | ||
| Q1 25 | — | $6.9M | ||
| Q4 24 | — | $6.6M | ||
| Q3 24 | — | $823.2K | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $-14.6M | $248.3M | ||
| Q3 25 | $-11.4M | $248.0M | ||
| Q2 25 | $-7.5M | $244.6M | ||
| Q1 25 | $-4.8M | $226.4M | ||
| Q4 24 | $-1.2M | $195.1M | ||
| Q3 24 | $2.2M | $205.0M | ||
| Q2 24 | $5.3M | $8.8M | ||
| Q1 24 | $9.5M | $9.0M |
| Q4 25 | $115.0M | $380.4M | ||
| Q3 25 | $107.7M | $321.4M | ||
| Q2 25 | $106.9M | $315.3M | ||
| Q1 25 | $98.3M | $284.6M | ||
| Q4 24 | $106.1M | $266.1M | ||
| Q3 24 | $97.7M | $296.5M | ||
| Q2 24 | $96.4M | $19.5M | ||
| Q1 24 | $101.4M | $19.8M |
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.09× | ||
| Q2 25 | — | 0.03× | ||
| Q1 25 | — | 0.03× | ||
| Q4 24 | — | 0.03× | ||
| Q3 24 | — | 0.00× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $3.2M | $52.0M |
| Free Cash FlowOCF − Capex | $3.0M | $51.2M |
| FCF MarginFCF / Revenue | 15.1% | 129.3% |
| Capex IntensityCapex / Revenue | 0.7% | 2.0% |
| Cash ConversionOCF / Net Profit | — | 3.66× |
| TTM Free Cash FlowTrailing 4 quarters | $5.3M | $23.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.2M | $52.0M | ||
| Q3 25 | $3.2M | $-20.9M | ||
| Q2 25 | $-2.5M | $-8.3M | ||
| Q1 25 | $2.9M | $1.9M | ||
| Q4 24 | $-2.6M | $-7.3M | ||
| Q3 24 | $1.1M | $5.0M | ||
| Q2 24 | $311.0K | $19.2M | ||
| Q1 24 | $477.0K | $3.7M |
| Q4 25 | $3.0M | $51.2M | ||
| Q3 25 | $2.5M | $-20.9M | ||
| Q2 25 | $-2.8M | $-8.6M | ||
| Q1 25 | $2.7M | $1.7M | ||
| Q4 24 | $-2.7M | $-7.9M | ||
| Q3 24 | $1.1M | $4.6M | ||
| Q2 24 | $264.0K | $18.3M | ||
| Q1 24 | $281.0K | $3.0M |
| Q4 25 | 15.1% | 129.3% | ||
| Q3 25 | 14.2% | -48.3% | ||
| Q2 25 | -17.2% | -19.9% | ||
| Q1 25 | 16.2% | 3.5% | ||
| Q4 24 | -17.3% | -17.8% | ||
| Q3 24 | 7.4% | 8.7% | ||
| Q2 24 | 1.8% | 34.5% | ||
| Q1 24 | 2.2% | 5.4% |
| Q4 25 | 0.7% | 2.0% | ||
| Q3 25 | 4.1% | 0.1% | ||
| Q2 25 | 2.2% | 0.7% | ||
| Q1 25 | 1.1% | 0.5% | ||
| Q4 24 | 0.3% | 1.3% | ||
| Q3 24 | 0.2% | 0.8% | ||
| Q2 24 | 0.3% | 1.6% | ||
| Q1 24 | 1.5% | 1.3% |
| Q4 25 | — | 3.66× | ||
| Q3 25 | — | -1.63× | ||
| Q2 25 | — | -3.39× | ||
| Q1 25 | — | 0.09× | ||
| Q4 24 | — | -1.12× | ||
| Q3 24 | — | 1.77× | ||
| Q2 24 | — | 1.04× | ||
| Q1 24 | — | 0.20× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AIP
| License And Maintenance | $17.5M | 87% |
| Variable Royalties And Other | $2.6M | 13% |
SBC
| Franchising | $10.3M | 26% |
| Medical Corporation Shobikai | $8.1M | 21% |
| Medical Corporation Nasukai | $7.2M | 18% |
| Management Services | $6.3M | 16% |
| Rental Services | $4.3M | 11% |
| Medical Corporation Association Furinkai | $3.0M | 8% |
| Japan Medical And Beauty Inc | $656.5K | 2% |
